Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Targeting KRAS in Lung Cancer: The Past, Present, and Future - ILCN.org (ILCN/WCLC)
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib - Lacasta‐Plasin - 2021 - Clinical Genetics - Wiley Online Library
Notorious KRAS: Taking down cancer researchers' biggest foe
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells: Cell
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein | PNAS
Frontiers | Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS
Targeting Mutant KRAS for Immunogenic Cell Death Induction: Trends in Pharmacological Sciences
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
KRAS: Kirsten RAT Sarcoma Viral Oncogenic Homolog
KRAS Biomarker | Colorectal Cancer Alliance
Cancers | Free Full-Text | KRAS in NSCLC: State of the Art and Future Perspectives
Small molecule combats cancer-causing KRAS protein at last
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
Vintage KRAS BRNO Narodni Podnik Czechoslovakian Army Visor Hat SZ 57 NICE SHAPE | eBay
The current state of the art and future trends in RAS-targeted cancer therapies | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | KRAS G12C Mutations in NSCLC: From Target to Resistance
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
JCM | Free Full-Text | KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Cureus | KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer | Article
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
